|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1133 S.W. Topeka Blvd. |
Address2 |
|
| City | Topeka |
State | KS |
Zip Code | 66629-0001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 323876-12
|
||||||||
|
6. House ID# 397350000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Sunee Mickle |
Date | 1/21/2025 9:26:52 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/ telehealth flexibilities; Mental Health Care; Youth Mental Health; Site neutral payment reform; hospital billing; Transparency in coverage; Surprise Billing; Prior Authorization; Hospital Consolidation; Employer-provided health coverage; Cyber attack & Cybersecurity; Provider Directories; Artificial Intelligence; Maternal Health; ; 2026 Proposed NBPP/Individual Market/ACA exchanges; Rural healthcare; CMS Transforming Maternal Health (TMaH) model; No surprises enforcement
S. 3548 Health Care PRICE Transparency Act
To amend the Public Health Service Act to provide for hospital and insurer price transparency.
Sponsor: Sen. Braun, Mike [R-IN]
H.R. 4818, Treat and Reduce Obesity Act
To amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes.
Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]
S.2407 - Treat and Reduce Obesity Act of 2023
To amend title XVIII of the Social Security Act to provide for the coordination of programs to prevent and treat obesity, and for other purposes.
Sponsor: Sen. Carper, Thomas R. [D-DE]
H.R.2630 - Safe Step Act
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes.
Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]
S.652 - Safe Step Act
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes.
Sponsor: Sen. Murkowski, Lisa [R-AK]
S. 1001 Telehealth Expansion Act of 2023
To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
Sponsor: Sen. Daines, Steve [R-MT]
H.R. 1843 - Telehealth Expansion Act
To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
Sponsor: Rep. Steel, Michelle [R-CA-45]
H.R. 3305, Black Maternal Health Momnibus Act
To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
Sponsor: Rep. Underwood, Lauren [D-IL-14]
S.1606 - Black Maternal Health Momnibus Act
To end preventable maternal mortality, severe maternal morbidity, and maternal health disparities in the United States, and for other purposes.
Sponsor: Sen. Booker, Cory A. [D-NJ]
H.R.3226 - PREEMIE Reauthorization Act of 2023
To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act.
Sponsor: Rep. Eshoo, Anna G. [D-CA-16]
H.R.3838 - Preventing Maternal Deaths Reauthorization Act of 2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Rep. Burgess, Michael C. [R-TX-26]
S.2415 - Preventing Maternal Deaths Reauthorization Act of 2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy-associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Sen. Capito, Shelley Moore [R-WV]
S.1869 - SITE Act
To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Sponsor: Sen. Braun, Mike [R-IN]
H.R.3417 - FAIR Act
To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider.
Sponsor: Rep. Hern, Kevin [R-OK-1]
H.R. 5378 Lower Costs, More Transparency Act
To promote price transparency in the health care sector, and for other purposes.
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
H.R.4531 - Support for Patients and Communities Reauthorization Act
To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes.
Sponsor: Rep. Guthrie, Brett [R-KY-2]
S.3393 - SUPPORT for Patients and Communities Reauthorization Act
To reauthorize the SUPPORT for Patients and Communities Act, and for other purposes.
Sponsor: Sen. Sanders, Bernard [I-VT]
H.R.3630 - No Surprises Act
To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes.
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
H.R. 5012, SHINE for Autumn Act
To improve research and data collection on stillbirths, and for other purposes.
Sponsor: Rep. Kim, Young [R-CA-40]
S. 3430, Better Mental Health Care, Lower Cost Drugs, and Extenders Act
To amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes.
Sponsor: Sen. Wyden, Ron [D-OR]
S. 1573 - PREEMIE Reauthorization Act of 2023
To reauthorize the Prematurity Research Expansion and Education for Mothers who deliver Infants Early Act.
Sponsor: Sen. Bennet, Michael F. [D-CO]
H.R. 10545, American Relief Act, 2025
Making further continuing appropriations for the fiscal year ending September 30, 2025, and for other purposes.
Sponsor: Rep. Cole, Tom [R-OK-4]
H.R. 5163 TREATS Act
To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes.
Sponsor: Rep. Trone, David J. [D-MD-6]
S.3193 - TREATS Act
To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes.
Sponsor: Sen. Whitehouse, Sheldon [D-RI]
H.R. 4366, Consolidated Appropriations Act of 2024
This act provides FY2024 appropriations for several federal departments and agencies. It also extends several expiring programs and authorities, including various public health programs.
Sponsor: Rep. Carter, John R. [R-TX-31]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sunee |
Mickle |
|
Vice President of Government and Community Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Advantage & MA Rate Notice
H.R. 7623, Telehealth Modernization Act
To amend title XVIII of the Social Security Act to make permanent certain telehealth flexibilities under the Medicare program.
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sunee |
Mickle |
|
Vice President of Government and Community Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
340B Program/Transparency; generics access
S. 1114, Expanding Access to Low-Cost Generics Act
To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period.
Sponsor: Sen. Smith, Tina [D-MN]
S. 2305 - Biosimilar Red Tape Elimination Act
To improve the requirements for making a determination of interchangeability of a biological product and its reference product.
Sponsor: Sen. Lee, Mike [R-UT]
S. 127 - Pharmacy Benefit Manager Transparency Act of 2023
To prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Sponsor: Sen. Cantwell, Maria [D-WA]
S. 148 - Stop STALLING Act
A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
Sponsor: Sen. Amy Klobuchar (D-MN)
S.1339 - Pharmacy Benefit Manager Reform Act
To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage.
Sponsor: Sen. Sanders, Bernard [I-VT]
S. 775, Increasing Transparency in Generic Drug Applications
To provide for increased transparency in generic drug applications.
Sponsor: Sen. Hassan, Margaret Wood [D-NH]
H.R. 9070, Affordable Prescriptions for Patients Act of 2024
To amend title 35, United States Code, to prohibit product hopping, and for other purposes.
Sponsor: Rep. Issa, Darrell [R-CA-48]
S. 150 - Affordable Prescriptions for Patients Act of 2023
To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
Sponsor: Sen. Cornyn, John [R-TX]
S.1542, DRUG Act
To improve services provided by pharmacy benefit managers.
Sponsor: Sen. Marshall, Roger [R-KS]
H.R.6094 - Providing Realistic Opportunity To Equal and Comparable Treatment (PROTECT) for Rare Act
To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes.
Sponsor: Rep. Matsui, Doris O. [D-CA-7]
S. 142 - Preserve Access to Affordable Generics and Biosimilars Act
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
Sponsor: Sen. Klobuchar, Amy [D-MN]
S. 1067, Ensuring Timely Access to Generics Act
To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions.
Sponsor: Sen. Shaheen, Jeanne [D-NH]
H.R.1359 - Modernizing Opioid Treatment Access Act
To expand the take-home prescribing of methadone through pharmacies.
Sponsor: Rep. Norcross, Donald [D-NJ-1]
S.644 - Modernizing Opioid Treatment Access Act
To expand the take-home prescribing of methadone through pharmacies.
Sponsor: Sen. Markey, Edward J. [D-MA]
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sunee |
Mickle |
|
Vice President of Government and Community Relations |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |